Berberine

Berberine is an isoquinoline alkaloid found in various medicinal plants — including Berberis aristata, Hydrastis canadensis (goldenseal) and Coptis chinensis. It is one of the natural compounds with the widest range of documented pharmacological actions: activates AMPK (AMP-activated kinase), improves insulin sensitivity, modulates intestinal microbiota, has antimicrobial action and may inhibit hepatic glucose production. It is frequently compared to metformin in its mechanism of action for glycemic control.

• Improved insulin sensitivity and glycemic control
• Reduction of fasting and postprandial blood glucose
• LDL and triglyceride reduction and improved lipid profile
• Intestinal microbiota modulation
• Weight loss support via improved insulin resistance
• Anti-inflammatory and antioxidant action
• Possible cardiovascular health support

• •People with insulin resistance or pre-diabetes
• •Individuals with metabolic syndrome
• •People with dyslipidemia (elevated cholesterol and triglycerides)
• •Those seeking natural glycemic control
• •People with overweight related to insulin resistance
• •Those wanting intestinal microbiota support

500mg, 2 to 3 times per day (total 1,000–1,500mg/day), always before main meals. Splitting into doses is essential — the half-life is short and administration with meals maximizes the glycemic effect.

Berberine is a supplement with a robust pharmacological profile — closer to a medication than most herbal medicines. Its efficacy for glycemic control is comparable to metformin in direct studies. It should be taken BEFORE meals to maximize the effect on postprandial glucose. The oral bioavailability of pure berberine is limited — formulations with phospholipids (phytosomal berberine) significantly improve absorption. Drug interactions are important — especially with hypoglycemics, anticoagulants and medications metabolized by CYP3A4.

Berberine has one of the most robust evidence profiles among natural compounds. A seminal study in the Journal of Clinical Endocrinology & Metabolism compared berberine (500mg 3x/day) with metformin (500mg 3x/day) in type 2 diabetics — equivalent results for glycated hemoglobin, fasting blood glucose and lipids. Meta-analyses confirm efficacy for glycemic control, dyslipidemia and weight loss. The AMPK mechanism is the same as metformin — hence the frequent comparison.

Gastrointestinal discomfort is the most common side effect — especially at the start of use. Nausea, cramps and diarrhea may occur, especially at high doses or without food. Hypoglycemia in combination with antidiabetic medications — monitor. May reduce blood pressure. Contraindicated during pregnancy. Important interactions with anticoagulants (warfarin) and medications metabolized by CYP3A4.